title: Essential thrombocythemia.
abstract: Essential thrombocythemia is a distinct clinical entity within the spectrum of myeloproliferative disorders. There is as yet no pathognomonic diagnostic test, and patients who currently fall into the category of essential thrombocythemia are likely to be heterogeneous. This article discusses diagnostic criteria, clinical features, prognosis, and management.
authors.affiliation: Department of Haematology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK. claire.harrison@gstt.sthames.nhs.uk
authors.forename: Claire N
authors.initials: CN
authors.lastname: Harrison
authors.forename: Anthony R
authors.initials: AR
authors.lastname: Green
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy; D012307:Risk Factors; D013920:Thrombocythemia, Essential / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*
chemical_list: D001241:Aspirin